U.S. Supreme Court Rejects Pharma Industry Challenge to Medicare Drug Price Plan
The U.S. Supreme Court on Monday declined to hear a major challenge from leading pharmaceutical companies against the Medicare drug price negotiation program introduced under former President Joe Biden’s Inflation Reduction Act of 2022....
U.S. to Fast-Track Medicare Payments for New Medical Devices
U.S. health regulators are preparing to introduce a new program aimed at accelerating federal payments for medical devices covered under Medicare, according to a report by the Financial Times. The initiative is expected to...
U.S. To Unveil New Medicare Drug Prices in Major Move to Cut Health Care Costs
The U.S. government is expected to announce negotiated prices this week for 15 of the highest-cost prescription drugs covered under Medicare, marking a significant signal of the Trump administration’s push to reduce healthcare expenses....